Overall, the study indicates that a novel USP10‐POLR2A‐SLC7A11 axis regulates ferroptosis, positioning USP10 as a potential therapeutic target in patients with HNSCC. The gene discussed is USP10; the disease is head and neck squamous cell carcinoma.